DuraGraft vascular conduit preservation solution in patients undergoing coronary artery bypass grafting: rationale and design of a within-patient randomised multicentre trial

INTRODUCTION: Saphenous vein grafts (SVGs) remain the most often used conduits in coronary artery bypass grafting (CABG). However, they are prone to vein graft disease (VGD) during follow-up, which may compromise clinical outcomes. Injury to the SVG endothelium during harvesting and storage promotes...

Descripción completa

Detalles Bibliográficos
Autores principales: Ben Ali, Walid, Voisine, Pierre, Olsen, Peter Skov, Jeanmart, Hugues, Noiseux, Nicolas, Goeken, Tracy, Satishchandran, Vilas, Cademartiri, Filippo, Cutter, Garry, Veerasingam, Dave, Brown, Craig, Emmert, Maximilian Y, Perrault, Louis P
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2018
Materias:
Coronary Artery Disease
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5905829/
https://www.ncbi.nlm.nih.gov/pubmed/29682294
http://dx.doi.org/10.1136/openhrt-2018-000780

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5905829/
https://www.ncbi.nlm.nih.gov/pubmed/29682294
http://dx.doi.org/10.1136/openhrt-2018-000780

Ejemplares similares